APA (7th ed.) Citation

Mori, M., Shizunaga, H., Harada, H., Tajiri, Y., Murata, Y., Terada, K., . . . Enjoji, M. (2022). Oxytocin treatment improves dexamethasone‐induced depression‐like symptoms associated with enhancement of hippocampal CREB‐BDNF signaling in female mice. Neuropsychopharmacology Reports, 42(3), 356. https://doi.org/10.1002/npr2.12271

Chicago Style (17th ed.) Citation

Mori, Masayoshi, Hiromi Shizunaga, Hiroyoshi Harada, Yuki Tajiri, Yusuke Murata, Kazuki Terada, Kenji Ohe, and Munechika Enjoji. "Oxytocin Treatment Improves Dexamethasone‐induced Depression‐like Symptoms Associated with Enhancement Of hippocampal CREB‐BDNF Signaling in Female Mice." Neuropsychopharmacology Reports 42, no. 3 (2022): 356. https://doi.org/10.1002/npr2.12271.

MLA (9th ed.) Citation

Mori, Masayoshi, et al. "Oxytocin Treatment Improves Dexamethasone‐induced Depression‐like Symptoms Associated with Enhancement Of hippocampal CREB‐BDNF Signaling in Female Mice." Neuropsychopharmacology Reports, vol. 42, no. 3, 2022, p. 356, https://doi.org/10.1002/npr2.12271.